Copolymer

All Categories Medications / Interventions » Cc » Copolymer

A Double Blinded, Placebo Controlled, Randomized Study Comparing Rituximab Induction Therapy Followed by Glatiramer Acetate Therapy to Glatiramer Acetate Monotherapy in Patients With Relapsing Forms of Multiple Sclerosis

Condition: Multiple Sclerosis
Interventions: Drug: Rituximab; Drug: Glatiramer Acetate
Sponsors: University of Colorado, Denver; University of Colorado, Denver; University of Colorado Hospital; Rocky Mountain Multiple Sclerosis Center
Recruiting - verified March 2012
To Assess the Efficacy, Safety and Tolerability of Glatiramer Acetate (GA) 20 mg/0.5 ml New Formulation Administered Daily by Subcutaneous (SC) Injection in Subjects With RRMS

Condition: Relapsing-Remitting Multiple Sclerosis
Interventions: Drug: Glatiramer Acetate; Drug: Matching placebo
Sponsors: Teva Pharmaceutical Industries; Teva Pharmaceutical Industries
Recruiting - verified May 2012
Glatiramer Acetate for Multiple Sclerosis With Autoimmune Comorbidities

Condition: Relapsing Remitting Multiple Sclerosis
Intervention:
Sponsors: University of Southern California; University of Southern California; Teva Pharmaceuticals USA
Recruiting - verified November 2011
Diclofenac Sodium Topical Gel to Reduce Injection Site Discomfort in Patients With Multiple Sclerosis Taking Glatiramer Acetate

Condition: Multiple Sclerosis
Interventions: Drug: diclofenac sodium topical gel; Other: Placebo
Sponsors: Brown, Theodore R., M.D., MPH; Brown, Theodore R., M.D., MPH; Teva Neuroscience, Inc.
Recruiting - verified October 2011

Main Menu

Clinical Trial Categories

Clinical Trial Locations

Sponsors/Recruiting

Join Clinical Trials

Copolymer Clinical Trials

Copolymer

Copolymer